X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-10 | RARE | Horn Howard | CFO | S - Sale | $52.76 | -7,465 | 92,301 | -7% | -$393,853 | ||||||
2024-09-03 | RARE | Kakkis Emil D | Pres, CEO | S - Sale | $55.85 | -20,000 | 2,788,582 | -1% | -$1,117,000 | ||||||
2024-09-03 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale | $56.19 | -91 | 41,551 | 0% | -$5,113 | ||||||
2024-08-06 | RARE | Kakkis Emil D | Pres, CEO | S - Sale | $50.17 | -20,000 | 2,808,582 | -1% | -$1,003,400 | ||||||
2024-07-02 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $40.98 | -584 | 12,009 | -5% | -$23,932 | ||||||
2024-06-12 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale | $45.00 | -9,806 | 57,981 | -14% | -$441,270 | ||||||
2024-06-10 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $41.10 | -1,737 | 7,248 | -19% | -$71,391 | ||||||
2024-05-02 | RARE | Crombez Eric | EVP, Chief Medical Officer | S - Sale | $43.66 | -354 | 48,431 | -1% | -$15,456 | ||||||
2024-04-18 | RARE | Crombez Eric | EVP, Chief Medical Officer | S - Sale | $44.10 | -142 | 48,785 | 0% | -$6,262 | ||||||
2024-03-11 | RARE | Kassberg Thomas Richard | CBO, EVP | S - Sale | $49.93 | -11,509 | 252,823 | -4% | -$574,644 | ||||||
2024-03-07 | RARE | Fust Matthew K | Dir | S - Sale | $50.88 | -12,195 | 14,860 | -45% | -$620,443 | ||||||
| D | 2024-03-01 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale+OE | $53.76 | -3,756 | 67,340 | -5% | -$201,923 | |||||
| D | 2024-03-01 | RARE | Kassberg Thomas Richard | CBO, EVP | S - Sale+OE | $53.76 | -1,011 | 264,332 | 0% | -$54,351 | |||||
| D | 2024-03-01 | RARE | Pinion John Richard | See Remarks | S - Sale+OE | $53.76 | -4,173 | 89,268 | -4% | -$224,340 | |||||
| D | 2024-03-01 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale+OE | $53.76 | -341 | 41,380 | -1% | -$18,332 | |||||
| D | 2024-03-01 | RARE | Crombez Eric | EVP, Chief Medical Officer | S - Sale+OE | $53.76 | -1,238 | 48,927 | -2% | -$66,555 | |||||
| D | 2024-03-01 | RARE | Harris Erik | EVP, Chief Commercial Officer | S - Sale+OE | $53.76 | -4,768 | 67,163 | -7% | -$256,328 | |||||
2024-02-07 | RARE | Kakkis Emil D | Pres, CEO | S - Sale | $45.00 | -30,000 | 2,803,755 | -1% | -$1,350,000 | ||||||
2023-12-29 | RARE | Kakkis Emil D | Pres, CEO | S - Sale | $47.87 | -30,000 | 2,833,755 | -1% | -$1,436,100 | ||||||
| D | 2023-10-23 | RARE | Kassberg Thomas Richard | CBO, EVP | S - Sale+OE | $32.78 | -39,878 | 246,860 | -14% | -$1,307,201 | |||||
| D | 2023-10-19 | RARE | Kakkis Emil D | Pres, CEO | S - Sale+OE | $33.52 | -47,853 | 2,863,728 | -2% | -$1,604,033 | |||||
| D | 2023-09-07 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale+OE | $40.80 | -2,163 | 23,614 | -8% | -$88,249 | |||||
2023-09-05 | RARE | Harris Erik | EVP, Chief Commercial Officer | S - Sale | $37.96 | -6,000 | 51,281 | -10% | -$227,760 | ||||||
2023-09-01 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale | $37.15 | -970 | 23,777 | -4% | -$36,032 | ||||||
2023-06-30 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $46.76 | -585 | 8,985 | -6% | -$27,355 | ||||||
2023-06-19 | RARE | Harris Erik | EVP, Chief Commercial Officer | S - Sale | $48.20 | -305 | 57,281 | -1% | -$14,701 | ||||||
| D | 2023-06-08 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale+OE | $51.65 | -1,485 | 9,570 | -13% | -$76,700 | |||||
2023-05-18 | RARE | Pinion John Richard | See Remarks | S - Sale | $50.00 | -2,012 | 74,744 | -3% | -$100,600 | ||||||
2023-05-04 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale | $45.00 | -4,378 | 51,982 | -8% | -$197,010 | ||||||
2023-03-01 | RARE | Bedrosian Camille L | EVP, Chief Medical Officer | S - Sale | $45.25 | -3,881 | 46,720 | -8% | -$175,615 | ||||||
| D | 2023-03-01 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale+OE | $45.25 | -3,161 | 56,139 | -5% | -$143,035 | |||||
| D | 2023-03-01 | RARE | Kassberg Thomas Richard | CBO, EVP | S - Sale+OE | $45.27 | -1,968 | 246,860 | -1% | -$89,091 | |||||
| D | 2023-03-01 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale+OE | $45.65 | -100 | 21,715 | 0% | -$4,565 | |||||
| D | 2023-03-01 | RARE | Huang Dennis Karl | See Remarks | S - Sale+OE | $45.65 | -389 | 64,715 | -1% | -$17,758 | |||||
| D | 2023-03-01 | RARE | Pinion John Richard | See Remarks | S - Sale+OE | $45.26 | -3,755 | 76,160 | -5% | -$169,951 | |||||
| D | 2023-03-01 | RARE | Harris Erik | EVP, Chief Commercial Officer | S - Sale+OE | $45.25 | -3,664 | 57,344 | -6% | -$165,796 | |||||
2023-02-28 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale | $43.40 | -639 | 15,558 | -4% | -$27,733 | ||||||
2022-12-30 | RARE | Kakkis Emil D | Pres, CEO | S - Sale | $45.57 | -19,582 | 2,824,385 | -1% | -$892,352 | ||||||
2022-12-21 | RARE | Huizenga Theodore Alan | SVP, Chief Accounting Officer | S - Sale | $43.96 | -2,031 | 16,197 | -11% | -$89,283 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |